Sort
82,697 grants matching “vaccine development”
PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
$2,666,802Fred Hutchinson Cancer Research Center · P50 · FY2002 · CA
Conference: Banff International Research Station
$2,666,668Malabika Pramanik · University Of British Columbia · · FY2023 · MPS
Development of a Vaccine for HIVAIDS: Humoral Immunity
$2,666,567Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,666,257Shaunna Shen · Duke University · N01 · FY2022 · AI
BSL-4 Evaluation Core (Core B)
$2,665,747Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2019 · AI
Northwestern University Clinical Trial Unit
$2,665,678Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2013 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$2,665,274Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2015 · AI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,664,477Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,664,477Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,663,362Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2013 · AI
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,661,553Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2020 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,660,765Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2014 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,660,334Stephen C Harrison · Boston Children'S Hospital · P01 · FY2020 · AI
Development of Novel Immunogens for Vaccines to HIV-1
$2,659,826Robert Gerald Whalen · Maxygen, Inc. · P01 · FY2006 · AI
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,658,245Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2021 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$2,658,055Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2021 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$2,658,032Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
$2,656,876Kenneth E Palmer · University Of Louisville · UC7 · FY2025 · AI
HIV Database and Analysis Unit
$2,656,835National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
University of Puerto Rico Clinical Trials Unit
$2,656,505Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2007 · AI
Task V08: Process Development for Scale-up of Vero Cells on Micro-Carriers for Manufacturing of a Live-Attenuated RSV Vaccine
$2,656,200Arbelo Cristina · Idt Biologika Gmbh · N01 · FY2019 · AI
BSL-4 Evaluation Core (Core B)
$2,655,768Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2020 · AI
Predictors and determinants of pediatric immunity (Peds)
$2,654,646John S Tsang · Yale University · P01 · FY2025 · AI
HIV Prevention Trials Network: Network Laboratory
$2,654,477Susan H Eshleman · Johns Hopkins University · U01 · FY2010 · AI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,654,299Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA